Correlation Between LG Uplus and DongKook Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both LG Uplus and DongKook Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LG Uplus and DongKook Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between LG Uplus and DongKook Pharmaceutical Co, you can compare the effects of market volatilities on LG Uplus and DongKook Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LG Uplus with a short position of DongKook Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of LG Uplus and DongKook Pharmaceutical.

Diversification Opportunities for LG Uplus and DongKook Pharmaceutical

-0.55

Correlation Coefficient

LG Uplus  DongKook Pharmaceutical

Excellent diversification

The 3 months correlation between 032640 and DongKook is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding LG Uplus and DongKook Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DongKook Pharmaceutical and LG Uplus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LG Uplus are associated (or correlated) with DongKook Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DongKook Pharmaceutical has no effect on the direction of LG Uplus i.e., LG Uplus and DongKook Pharmaceutical go up and down completely randomly.

Pair Corralation between LG Uplus and DongKook Pharmaceutical

Assuming the 90 days trading horizon LG Uplus is expected to generate 1.03 times more return on investment than DongKook Pharmaceutical. However, LG Uplus is 1.03 times more volatile than DongKook Pharmaceutical Co. It trades about -0.05 of its potential returns per unit of risk. DongKook Pharmaceutical Co is currently generating about -0.17 per unit of risk. If you would invest  1,124,000  in LG Uplus on September 25, 2024 and sell it today you would lose (25,000) from holding LG Uplus or give up 2.22% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

LG Uplus  vs.  DongKook Pharmaceutical Co

LG Uplus

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in LG Uplus are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, LG Uplus may actually be approaching a critical reversion point that can send shares even higher in January 2025.

DongKook Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DongKook Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, DongKook Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with LG Uplus and DongKook Pharmaceutical

The main advantage of trading using opposite LG Uplus and DongKook Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LG Uplus position performs unexpectedly, DongKook Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DongKook Pharmaceutical will offset losses from the drop in DongKook Pharmaceutical's long position.

The idea behind LG Uplus and DongKook Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.